Additionally, SM’s presence during IL-2 priming increases NK cell cytotoxic capacity via activation of the TNF-α–NF-kB axis, prompting to use SM as a novel strategy acting through cancer cell sensitization and NK cell functional enhancement [47]. Here, TNF is linked to cancer.